Free Glucose Sensors for Adults with Poorly Controlled Type 2 Diabetes
Studies free continuous glucose monitors in adults with poorly controlled type 2 diabetes.
Key facts
- Who runs it
- Yale University
- Where
- New Haven, United StatesSee the site
- Trial code
- Registry title
- Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access
- Status
- Recruiting
- People taking part
- 17 people, planned
- Started
- 12 Nov 2024
- Planned end
- Jun 2026
- Type of study
- Interventional
- Treatments tested
- Continuous Glucose Monitor (CGM)
- Record updated
- 3 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with poorly controlled type 2 diabetes who use insulin and cannot afford CGM sensors. They are patients of Fair Haven Community Health Care.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Type 2 diabetes with an A1c of 8.0 or higher within two weeks of enrollment
- Earlier treatment
- On insulin for at least one year, with or without other diabetes medicines
- Biomarker or test result
- A1c of 8.0 or higher within two weeks of enrollment
Main reasons for not taking part
- Never used insulin
- Diabetic ketoacidosis (DKA) in the past 6 months
- End-stage renal disease (ESRD)
- Medical reason not to use a CGM
- Insurance that would pay enough for the person to buy CGM sensors
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Diagnosed with type 2 diabetes mellitus
- A1c greater than or equal to 8.0 within two weeks of the time of enrollment
- On insulin for at least one year +/- other antihyperglycemics
- Ability and willingness to wear CGM for 14-day periods throughout the trial period
- Ability and willingness to comply with provider-directed adjustments to medication regimen
- Inability to afford CGM sensors; A note on Vulnerable Populations: Many of FHCHC's patients are economically disadvantaged and of minority backgrounds; the clinic's patient base may be considered to constitute a vulnerable population. As such, recruitment and enrollment will be conducted within a vulnerable population. The nature of the study requires this, and the results are intended to directly benefit this population through the potential for improved glycemic control and quality of life
Who cannot take part
- Diabetic ketoacidosis (DKA) in previous 6 months
- End-Stage Renal Disease (ESRD)
- Insulin naïve
- Contraindications to CGM use
- Active insurance plan that would provide enough of a subsidy for participant to feasibly purchase CGM sensors
- Pregnancy
Where in United States
- Fair Haven Community Health Care (FHCHC)New Haven, United StatesContact: Justin A Dower, MDTaking people
About the trial
What the trial wants to find out
This non-blinded, non-randomized pre-post study will examine the impact of providing CGM sensors free of charge to adult patients of Fair Haven Community Health Care with poorly controlled type 2 diabetes on glycemic control and quality of life.
The group in the trial
- Poorly Controlled Type 2 Diabetes- CGMTreatment being tested
Participants will have CGM sensor placed at first visit and will be worn for 12 weeks. Sensor must be scanned 3 times daily. Adjustments to medication regimen will be recommended at 6 weeks. Follow-up appointments will be at 12 weeks and 24 weeks.
Treatment: Continuous Glucose Monitor (CGM)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- CGMs for All: Studying the Impact of Expanding CGM Access
- Plain-language title
- Free Glucose Sensors for Adults with Poorly Controlled Type 2 DiabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 3 December 2025